Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT05889650

External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial

Led by Brain Trauma Foundation · Updated on 2026-04-22

30

Participants Needed

6

Research Sites

209 weeks

Total Duration

On this page

Sponsors

B

Brain Trauma Foundation

Lead Sponsor

U

Uniformed Services University of the Health Sciences

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this phase 1 randomized controlled safety and feasibility clinical trial are to determine the safety of external lumbar drainage (ELD) in select patients with severe Traumatic Brain Injury (TBI). The main questions it aims to answer are (i) if ELD is feasible and (ii) safe to perform in severe TBI patients who have radiological evidence of patent basal cisterns and midline shift \<5mm without increasing the risk of neurological worsening or cerebral herniation. All participants will receive routine usual care. The study group will additionally have ELD for cerebrospinal fluid (CSF) drainage. A comparison will be made between the usual treatment plus ELD (interventional) groups, and the usual treatment (control) groups on incidence rate of neurological worsening or cerebral herniation events, and whether total hours with raised intracranial pressure (ICP) are different.

CONDITIONS

Official Title

External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 65 years
  • Glasgow Coma Scale (GCS) score between 3 and 8
  • Pupils symmetric and reactive in both eyes
  • Midline brain shift of 5 mm or less on brain CT scan
  • Patent (complete or partial) quadrigeminal cisterns on brain CT scan
  • Randomization and intervention can start within 24 hours of injury
  • ELD safety score of 5 or higher
Not Eligible

You will not qualify if you...

  • Glasgow Coma Scale (GCS) score greater than 8
  • Completely effaced (closed) basal cisterns on brain CT
  • Midline brain shift greater than 5 mm on CT
  • GCS score of 3 with dilated and fixed pupils
  • Evidence of uncal or tonsillar brain herniation on CT
  • Temporal lobe contusions with effaced ipsilateral cisterns
  • Penetrating traumatic brain injury
  • Previous hemicraniectomy (skull removal surgery)
  • Pregnancy
  • Prisoner status
  • Patients lacking capacity to consent or with advanced directives to forego aggressive care
  • Pre-existing conditions lowering functional status or life expectancy to less than 1 year
  • Contraindications for ELD: coagulopathy, use of blood thinners, low platelets (<50,000), or severe spinal deformity
  • Posterior fossa brain hemorrhage

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

University of Florida

Gainesville, Florida, United States, 32610

Actively Recruiting

2

Kansas University Medical Center

Kansas City, Kansas, United States, 66160

Actively Recruiting

3

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

4

Brooke Army Medical Center

Fort Sam Houston, Texas, United States, 78234

Actively Recruiting

5

University of Houston Medical Center

Houston, Texas, United States, 77030

Actively Recruiting

6

University of Texas

San Antonio, Texas, United States, 78249

Actively Recruiting

Loading map...

Research Team

C

Carlos Morales, MPH

CONTACT

H

Halinder S Mangat, MD, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here